Trial
NCT01574248
Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
Shire
Condition
ACE Inhibitor-associated Angioedema
Intervention
icatibant
Why stopped
DSMC recommended discontinuation for futility and feasibility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-17